Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:
“So happy to see this massive effort orchestrated by ESMO that started 3 years ago landing down with a practical guide defining line of treatment (LoT) published in Annals of Oncology.
Hope that will allow clinicians speak a common language (including MDTs) and will clarify approvals/indications of anticancer treatments in clinical practice.
Feel blessed to have been part of such a beautiful scientific journey.”
Title: ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours
Authors: K.S. Saini, M. Koopman, D. Martins-Branco, P. Bossi, S.Braendegaard Winther, M. Brahmi, I. Braña, E. Calvo, L. Castelo-Branco, I. Colombo, E. de Azambuja, D. De Ruysscher, R. Dienstmann, A-M.C. Dingemans, M. Ekholm, C. Gallois, V. Golfinopoulos, E. Grande, S. Halabi, E. Le Rhun, O. Le Saux, N.B. Leighl, S. Lonardi, S. Lorenzen, D. Lorusso, Giuseppe Minniti, G. Mountzios, J. Oldenburg, S.F. Oosting, P. Osterlund, J.L. Perez-Gracia, A. Pellat, S. Piperno-Neumann, R. Plummer, C. Porta, K. Punie, I. Ray-Coquard, J. Remon, C.H. Ruhlmann, P. Rutkowski, L.L. Siu, S. Stacchiotti, C. Suarez, K. Suijkerbuijk, J. Taieb, D. Trapani, A. Valachis, H.W.M. van Laarhoven, A. Vogel, A. Zer, G. Pentheroudakis, S. Delaloge, C. Twelves.
Other articles featuring Giannis Mountzios on OncoDaily.